Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers
Chengsong Cao, Qun Wang, Yong LiuDepartment of Oncology, Xuzhou Center Hospital, Xuzhou, Jiangsu, People’s Republic of ChinaPurpose: Co-delivery of drugs to achieve the synergistic anticancer effect is a promising strategy for lung cancer therapy. The purpose of this research is to develop a doxorub...
Saved in:
Main Authors: | Cao C (Author), Wang Q (Author), Liu Y (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers
by: Jin Y, et al.
Published: (2020) -
Optimization of indomethacin loaded nanostructured lipid carriers
by: Pattravee Niamprem, et al.
Published: (2016) -
Spray drying of fenofibrate loaded nanostructured lipid carriers
by: Dengning Xia, et al.
Published: (2016) -
Anastrozole Loaded Nanostructured Lipid Carriers : Preparation and Evaluation
by: Alaa Abdul-Jabbar Hashim, et al.
Published: (2021) -
Darifenacin Hydrobromide loaded nanostructured lipid carrier for oral administration
by: Ali kathem Ala Allah, et al.
Published: (2018)